Search

The Director will provide an important leadership role in Microbiology by overseeing the day to day operation of the ContraFect Microbiology Laboratory and the performance of clinical microbiology development studies in the field of protein

The Director will provide an important leadership role in Microbiology by overseeing the day to day operation of the ContraFect Microbiology Laboratory and the performance of clinical microbiology development studies in the field of protein

ContraFect has received a $7.2 Million grant from the US Army Medical Research and Development Command to advance their engineered phage lysin candidate CF-296 for Staphylococcus aureus infections.

ContraFect has received a $7.2 Million grant from the US Army Medical Research and Development Command to advance their engineered phage lysin candidate CF-296 for Staphylococcus aureus infections.

Micreos, a Dutch phage biotech company, secured 30 million Euro last month for its phage lysin technology. The company plans to use the funds for lysin development, and to launch its over-the-counter Gladskin product (anti-Staph aureus lysi

Micreos, a Dutch phage biotech company, secured 30 million Euro last month for its phage lysin technology. The company plans to use the funds for lysin development, and to launch its over-the-counter Gladskin product (anti-Staph aureus lysi